Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Concerns with Traditional PBM and Transparent Models Accelerates Demand for the First True Fiduciary PBM

      US-Rx

      News provided by

      US-Rx

      Dec 17, 2025, 09:15 ET

      Share this article

      Share this article


      With federal regulators intensifying scrutiny of PBM practices and employers facing mounting ERISA and CAA-2021 fiduciary exposure, the need for a fiduciary compliant, conflict-free pharmacy benefits model has never been more urgent. US-Rx Care— the nation's first fiduciary PBM—delivers a legally aligned, clinically rigorous, and financially transparent alternative that consistently reduces plan and member costs by 30–50%.

      HOLLYWOOD, Fla., Dec. 17, 2025 /PRNewswire/ -- A wave of federal scrutiny is exposing how legacy pharmacy benefit managers (PBMs) inflate drug costs and expose employers to potential legal jeopardy. Recent Federal Trade Commission (FTC) findings of drug dispensing from 2017 to 2022 uncovered $7.3 billion in PBM markups on specialty generics dispensed in PBM-owned pharmacies. The FTC uncovered another $1.4 billion in markups on prescriptions dispensed by pharmacies, confirming that vertically integrated PBMs profit from high drug prices. These practices have led to lawsuits against major employers over alleged Employee Retirement Income Security Act (ERISA) and Consolidated Appropriations Act (CAA-2021) violations tied to PBM contract misalignment that drives up prescription drug costs for plan enrollees.

      US-Rx Care, founded in 2007 as the nation's first fiduciary PBM, argues that the solution is clear: PBMs must be legally bound to act in the best interest of the plan and its members—not themselves.

      "Most PBMs steer utilization to maximize their own profits," said Renzo Luzzatti, President & CEO. "A true fiduciary PBM removes every financial conflict and is focused solely on delivering better outcomes at the lowest available cost." That's the standard ERISA requires, and the standard employers need."

      PBM Opacity Drives Costs and Employer Liability

      The FTC's latest findings deliver the strongest evidence to date that PBM incentives are fundamentally misaligned, putting PBM financial interests above all - with employers and patients picking up the tab. Among key FTC findings were:

      • The "Big 3" PBMs imposed hundreds to thousands of percent markups on specialty generics.
      • PBM-owned pharmacies captured disproportionate shares of the most profitable prescriptions.
      • PBMs steered patients to their own pharmacies and reimbursed them at higher rates than independents.
      • Spread pricing alone generated $1.4 billion in PBM profit on medications dispensed by retail pharmacies.
      • Plan sponsors and patients saw spending grow at double-digit rates, with 21% annual increases in commercial claims.
      • Lower-cost drugs were excluded from formularies in favor of high-rebate, high-cost alternatives.

      These findings confirm what employers have long experienced: PBMs profit when plan spending goes up, not down, which in turn creates a disincentive for PBMs to lower costs. As more unsavory PBM practices come to light, employers face not only unprecedented costs, but also fiduciary liability if they continue relying on traditional, conflict-ridden PBM service contracts.

      Fiduciary PBM Model: Built for Compliance and Cost Reduction
      US-Rx Care pioneered the fiduciary PBM model in 2007, operating under three non-negotiable ERISA principles: No conflicts of interest; act solely in the interest of the plan and its members and provide full transparency of all financial and utilization data. This means:

      • No pharmacy ownership.
      • 100% pass-through of rebates, discounts, and manufacturer revenue.
      • Clinical decisions based solely on safety, effectiveness, and lowest net cost.
      • Complete alignment with employers' own fiduciary duties under ERISA.

      "Transparency alone isn't enough," said Luzzatti. "It's not a word that is quantifiable nor has any legal meaning, and it still allows PBMs to define the rules. Fiduciary accountability eliminates all conflicted revenue streams and all self-dealing." "Employers using US-Rx Care consistently see 30–50% lower pharmacy spend in year one—validated independently by the Validation Institute—and roughly 30% lower costs for members.

      Right Rx™: Delivering Real-World Savings at Scale
      Among several core technologies delivering measurable cost savings is US-Rx Care's Right Rx™ platform which monitors pharmacy claims to identify and target over 2,500 cost savings and quality improvement scenarios across all clients. The platform engages prescribers directly and secures more than 70% clinician approval for lower-cost, equally effective therapies. More than 80% of members accept their prescriber approved changes, delivering large, immediate, and sustained savings for both plan sponsors and members.

      "Employers don't need another spreadsheet," Luzzatti said. "They need real pharmacy risk management. Right Rx gives them a doctor and member friendly path to better outcomes and lower cost."

      A Ready-Now Solution Aligned with All Major Reform Goals
      As Congress, the FTC, and AMA push for PBM reform, the fiduciary PBM model is emerging as the inevitable future. But employers don't need to wait for legislation. They can meet and be fully compliant with their fiduciary-duty requirements today by engaging a PBM like US-Rx Care bound by the same ERISA standards as plan sponsors.

      "Legacy PBMs have shown what happens when profit comes before patients—higher costs, opaque contracts, and rising litigation," said Luzzatti. "US-Rx Care proves the benefit when a PBM puts employers and members first."

      For more information about US-Rx Care's fiduciary PBM services, visit US-Rx Care.

      About US-Rx Care
      US-Rx Care is revolutionizing America's pharmacy benefits system by replacing opaque, profit-driven PBMs with a transparent, fiduciary model that puts employers and members first. Founded in 2007, the company combines clinical rigor, ethical contracting, and data-driven oversight to cut drug costs by up to 50% or more while also improving health outcomes. Operating under a legally binding ERISA fiduciary standard, US-Rx Care eliminates conflicts of interest, passes through 100% of manufacturer rebates and pharmacy discounts, and delivers measurable savings without compromising care. Privately owned and free from outside financial influence, US-Rx Care is setting the new standard for pharmacy benefit management—restoring trust, accountability, and real control for employers, benefits consultants, and health plans nationwide. 

      Website: www.us-rxcare.com

      References:

      • Federal Trade Commission. (2024, July). Pharmacy benefit managers: The powerful middlemen inflating drug costs and squeezing Main Street pharmacies – Interim staff report. U.S. Government Printing Office.
      • Federal Trade Commission. (2025, January 14). FTC releases second interim staff report on prescription drug middlemen.
      • Martin, K. (2025, March 17). What pharmacy benefit managers do — and how they contribute to drug spending. The Commonwealth Fund.
      • National Alliance of Healthcare Purchaser Coalitions. (2023, June). Addressing pharmacy benefit management misalignment.
      • Abrams, L. W. (2025, March 13). A pharmacy benefit manager insurance business model.
      • Mayer, K. (2025, June 6). How much of employers' annual claims do GLP-1 drugs account for? SHRM.

      Media Inquiries:
      Karla Jo Helms
      JOTO PR™
      727-777-4629
      Jotopr.com

      SOURCE US-Rx

      Modal title

      Also from this source

      As GLP-1 Spending Climbs, Employers Need to Look Beyond Price

      As GLP-1 Spending Climbs, Employers Need to Look Beyond Price

      GLP-1 medications are taking a growing share of employer pharmacy budgets, pushing self-funded plans to look beyond negotiated discounts and examine...

      Before Choosing a Transparent PBM, Employers Should Ask These 10 Questions

      Before Choosing a Transparent PBM, Employers Should Ask These 10 Questions

      Employer pharmacy costs are rising faster than healthcare costs overall. Business Group on Health estimates drug costs will increase 12% in 2026,...

      More Releases From This Source

      Explore

      Insurance

      Insurance

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Pharmaceuticals

      Pharmaceuticals

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.